Treatment of Antiphospholipid Syndrome in Non-Pregnant Women with a History of Obstetric APS

The patient is female, not pregnant, and presents with a history of obstetric antiphospholipid syndrome — without any history of arterial or venous thrombotic events. In this setting, prophylactic management requires careful individual risk–benefit evaluation before initiating or continuing therapy.

Current evidence supports a prophylactic antiplatelet strategy for eligible women in this scenario. The regimen involves a single oral antiplatelet agent; the complete specification — including dose, schedule, and individualization criteria — is detailed in the full structured protocol.